IL18 and prostate cancer: In the Asian population, although all the articles included in the meta-analysis showed that there is no association between IL-18 -607 C/A and prostate cancer risk, after meta-analysis, we found that IL-18 -607 C/A is associated with the prostate cancer risk as a protective factor, and is also associated with the prostate cancer risk in Caucasians correspondingly.